Photo of Sukrti Thonse

Associate, Corporate and Litigation Practice

Sukrti supports the firm's representation of clients in corporate transactions and in legal matters related to the healthcare sector, with experience across all stages of the corporate life cycle.

Her work includes the formation of corporate entities, including capitalization structures, fundraising, financing, strategic issues, and negotiations with investors. She provides support related to merger and acquisition transactions, venture capital financings, public offerings, regulatory due diligence reviews, private equity investments, regulatory disclosures in securities filings, and transactions involving FDA-regulated entities. She also assists clients with issues related to corporate governance and day-to-day business operations.

Sukrti has developed expertise related to HIPAA compliance and other healthcare privacy issues. She provides guidance on regulatory frameworks, including those associated with FDA regulations, the Anti-Kickback Statute, Stark Law, and other healthcare compliance concerns.

Contact information:

sthonse@greenbaumlaw.com | 732.476.2480 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

Private Equity (PE) firms continue to be significant players in U.S. healthcare, acquiring assets across various sectors such as physician practices, home health, behavioral health, and urgent care. However, recent legal developments and enforcement trends over the last five years underscore the increasing regulatory scrutiny and legal risks associated with these investments.

Antitrust Enforcement Is